Abstract
The role of surgical resection in malignant pleural mesothelioma (MPM) is controversial, but cancer-directed surgery has yielded long-term survivors and demonstrated 15% 5-year survival. The two operations developed for surgical resection, extrapleural pneumonectomy (EPP), and radical or extended pleurectomy/decortication (P/D) are described. In addition, this chapter summarizes the preoperative, perioperative, and postoperative management of these patients and the results of studies evaluating both procedures. Data and clinical experience suggest that P/D is better tolerated by patients, and evidence suggests survival is not worse. Although EPP is still performed in selected cases, the authors advocate radical P/D for most patients with MPM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aziz T, Jilaihawi A, Prakash D (2002) The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 22:298–305
Baldini EH, Richards WG, Gill RR et al (2015) Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 149:1374–1381
Batirel HF, Metintas M, Caglar HB et al (2008) Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 3:499–504
Burt BM, Cameron RB, Mollberg NM et al (2014) Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg 148:30–35
Butchart EG, Ashcroft T, Barnsley WC et al (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15–24
Cao C, Tian D, Park J et al (2014) A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83:240–245
Cho BC, Feld R, Leighl N et al (2014) A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the “SMART” approach for resectable malignant pleural mesothelioma. J Thorac Oncol 9:397–402
de Perrot M, Feld R, Cho BC et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27:1413–1418
de Perrot M, Feld R, Leighl NB et al (2016) Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 151:468–473
Flores RM (2005) The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 49(Suppl 1):S27–S32
Flores RM, Krug LM, Rosenzweig KE et al (2006) Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1:289–295
Flores RM, Zakowski M, Venkatraman E et al (2007) Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2:957–965
Flores RM, Pass HI, Seshan VE et al (2008a) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620–626. 6 e1–3
Flores RM, Routledge T, Seshan VE et al (2008b) The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 136:605–610
Flores RM (2009) Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21:149–153
Flores RM, Riedel E, Donington JS et al (2010) Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol 5:1649–1654
Flores RM (2016) Pleurectomy decortication for mesothelioma: the procedure of choice when possible. J Thorac Cardiovasc Surg 151:310–312
Gupta V, Mychalczak B, Krug L et al (2005) Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 63:1045–1052
Kindler HL, Karrison TG, Gandara DR et al (2012) Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol 30:2509–2515
Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27:3007–3013
McCormack PM, Nagasaki F, Hilaris BS et al (1982) Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 84:834–842
Ng JM, Hartigan PM (2008) Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol 21:21–27
Pass HI, Temeck BK, Kranda K et al (1997) Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 4:628–633
Patz EF Jr, Shaffer K, Piwnica-Worms DR et al (1992) Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 159:961–966
Richards WG, Zellos L, Bueno R et al (2006) Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 24:1561–1567
Rosenzweig KE, Zauderer MG, Laser B et al (2012) Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 83:1278–1283
Sarot IA (1949) Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 4:173–223
Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63. discussion p 65
Sugarbaker DJ, Jaklitsch MT, Bueno R et al (2004) Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128:138–146
Sugarbaker DJ, Wolf AS (2010) Surgery for malignant pleural mesothelioma. Expert Rev Respir Med 4:363–372
Sugarbaker DJ, Wolf AS, Chirieac LR et al (2011) Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg 40:298–303
Sugarbaker DJ, Gill RR, Yeap BY et al (2013) Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg 45:955–963
Sugarbaker DJ, Richards WG, Bueno R (2014) Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann Surg 260:577–580. discussion pp 80–82
Taioli E, Wolf AS, Camacho-Rivera M et al (2014) Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg 98:1020–1024
Taioli E, Wolf AS, Camacho-Rivera M et al (2015a) Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 Patients. PLoS One 10:e0145039
Taioli E, Wolf AS, Flores RM (2015b) Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg 99:472–480
Taioli E, Wolf AS, Moline JM et al (2015c) Frequency of surgery in black patients with malignant pleural mesothelioma. Dis Markers 2015:282145
Tilleman TR, Richards WG, Zellos L et al (2009) Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 138:405–411
Treasure T, Lang-Lazdunski L, Waller D et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763–772
Weder W, Kestenholz P, Taverna C et al (2004) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22:3451–3457
Weder W, Stahel RA, Bernhard J et al (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18:1196–1202
Wolf AS, Daniel J, Sugarbaker DJ (2009) Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21:132–148
Wolf AS, Jacobson FL, Tilleman TR et al (2010a) Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. Eur J Cardiothorac Surg 37:770–775
Wolf AS, Richards WG, Tilleman TR et al (2010b) Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg 90:949–956. discussion p 956
Wolf AS, Gill RR, Baldini EH et al (2012) Patterns of recurrence following pleurectomy/decortication for malignant pleural mesothelioma. In: Abstracts of 11th International Conference of the International Mesothelioma Interest Group
Yan TD, Boyer M, Tin MM et al (2009) Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. J Thorac Cardiovasc Surg 138:619–624
Conflict of Interest
The authors declare no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Wolf, A., Flores, R. (2017). Surgery Approaches in Mesothelioma. In: Testa, J. (eds) Asbestos and Mesothelioma. Current Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-53560-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-53560-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53558-6
Online ISBN: 978-3-319-53560-9
eBook Packages: MedicineMedicine (R0)